192 related articles for article (PubMed ID: 24002504)
1. The median informs the message: accuracy of individualized scenarios for survival time based on oncologists' estimates.
Kiely BE; Martin AJ; Tattersall MH; Nowak AK; Goldstein D; Wilcken NR; Wyld DK; Abdi EA; Glasgow A; Beale PJ; Jefford M; Glare PA; Stockler MR
J Clin Oncol; 2013 Oct; 31(28):3565-71. PubMed ID: 24002504
[TBL] [Abstract][Full Text] [Related]
2. Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in Advanced Gastric Cancer.
Vasista A; Stockler M; Martin A; Pavlakis N; Sjoquist K; Goldstein D; Gill S; Jain V; Liu G; Kannourakis G; Kim YH; Nott L; Snow S; Burge M; Harris D; Jonker D; Chua YJ; Epstein R; Bonaventura A; Kiely B
Oncologist; 2019 Nov; 24(11):e1102-e1107. PubMed ID: 30936377
[TBL] [Abstract][Full Text] [Related]
3. Estimating survival in advanced cancer: a comparison of estimates made by oncologists and patients.
Smith-Uffen MES; Johnson SB; Martin AJ; Tattersall MHN; Stockler MR; Bell ML; Detering K; Clayton JM; Silvester W; Clarke S; Vaccaro L; Beale P; Kiely BE
Support Care Cancer; 2020 Jul; 28(7):3399-3407. PubMed ID: 31781946
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of oncologists' estimates of expected survival time in advanced cancer.
Nahm SH; Martin AJ; Clayton JM; Grimison P; Moth EB; Pavlakis N; Sjoquist K; Smith-Uffen MES; Tognela A; Vasista A; Stockler MR; Kiely BE
JNCI Cancer Spectr; 2023 Oct; 7(6):. PubMed ID: 37963058
[TBL] [Abstract][Full Text] [Related]
5. Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer.
Stockler MR; Tattersall MH; Boyer MJ; Clarke SJ; Beale PJ; Simes RJ
Br J Cancer; 2006 Jan; 94(2):208-12. PubMed ID: 16404420
[TBL] [Abstract][Full Text] [Related]
6. Patient and oncologist estimates of survival in advanced cancer patients.
Kao SC; Butow P; Bray V; Clarke SJ; Vardy J
Psychooncology; 2011 Feb; 20(2):213-8. PubMed ID: 20878829
[TBL] [Abstract][Full Text] [Related]
7. Oncologists' and physiatrists' attitudes regarding rehabilitation for patients with advanced cancer.
Spill GR; Hlubocky FJ; Daugherty CK
PM R; 2012 Feb; 4(2):96-108. PubMed ID: 22373458
[TBL] [Abstract][Full Text] [Related]
8. Using three scenarios to explain life expectancy in advanced cancer: attitudes of patients, family members, and other healthcare professionals.
Nahm SH; Stockler MR; Martin AJ; Grimison P; Fox P; Zielinski R; Hawson GA; Tattersall MH; Kiely BE
Support Care Cancer; 2022 Sep; 30(9):7763-7772. PubMed ID: 35701634
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of the palliative prognostic score in hospitalized patients with advanced cancer.
Glare PA; Eychmueller S; McMahon P
J Clin Oncol; 2004 Dec; 22(23):4823-8. PubMed ID: 15570085
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer.
Ando M; Ando Y; Hasegawa Y; Shimokata K; Minami H; Wakai K; Ohno Y; Sakai S
Br J Cancer; 2001 Nov; 85(11):1634-9. PubMed ID: 11742480
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of Oncologists' Life-Expectancy Estimates Recalled by Their Advanced Cancer Patients: Correlates and Outcomes.
Lambden J; Zhang B; Friedlander R; Prigerson HG
J Palliat Med; 2016 Dec; 19(12):1296-1303. PubMed ID: 27574869
[TBL] [Abstract][Full Text] [Related]
12. How long have I got? Estimating typical, best-case, and worst-case scenarios for patients starting first-line chemotherapy for metastatic breast cancer: a systematic review of recent randomized trials.
Kiely BE; Soon YY; Tattersall MH; Stockler MR
J Clin Oncol; 2011 Feb; 29(4):456-63. PubMed ID: 21189397
[TBL] [Abstract][Full Text] [Related]
13. The oncologist's role in delivering palliative care.
Cherny N
Cancer J; 2010; 16(5):411-22. PubMed ID: 20890137
[TBL] [Abstract][Full Text] [Related]
14. Doctor-to-doctor communication of prognosis in metastatic cancer: a review of letters from medical oncologists to referring doctors.
Moth EB; Parry J; Stockler MR; Beale P; Blinman P; Della-Fiorentina S; Kiely BE
Intern Med J; 2015 Sep; 45(9):909-15. PubMed ID: 25851689
[TBL] [Abstract][Full Text] [Related]
15. Estimating survival time in older adults receiving chemotherapy for advanced cancer.
Moth EB; Blinman P; Stefanic N; Naganathan V; Grimison P; Stockler MR; Beale P; Martin A; Kiely BE
J Geriatr Oncol; 2020 May; 11(4):617-625. PubMed ID: 31501013
[TBL] [Abstract][Full Text] [Related]
16. Differences in pediatric oncologists' estimates of curability and treatment recommendations for patients with advanced cancer.
Wusthoff CJ; McMillan A; Ablin AR
Pediatr Blood Cancer; 2005 Feb; 44(2):174-81. PubMed ID: 15390284
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy.
Bedke J; Chun FK; Merseburger A; Scharpf M; Kasprzyk K; Schilling D; Sievert KD; Stenzl A; Kruck S
BJU Int; 2012 Dec; 110(11 Pt B):E771-7. PubMed ID: 23134582
[TBL] [Abstract][Full Text] [Related]
18. Influence of the gynecologic oncologist on the survival of ovarian cancer patients.
Chan JK; Kapp DS; Shin JY; Husain A; Teng NN; Berek JS; Osann K; Leiserowitz GS; Cress RD; O'Malley C
Obstet Gynecol; 2007 Jun; 109(6):1342-50. PubMed ID: 17540806
[TBL] [Abstract][Full Text] [Related]
19. Which is more valuable, longer survival or better quality of life? Israeli oncologists' and family physicians' attitudes toward the relative value of new cancer and congestive heart failure interventions.
Greenberg D; Hammerman A; Vinker S; Shani A; Yermiahu Y; Neumann PJ
Value Health; 2013; 16(5):842-7. PubMed ID: 23947979
[TBL] [Abstract][Full Text] [Related]
20. Predicting Survival for Patients With Metastatic Disease.
Benson KRK; Aggarwal S; Carter JN; von Eyben R; Pradhan P; Prionas ND; Bui JL; Soltys SG; Hancock S; Gensheimer MF; Koong AC; Chang DT
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):52-60. PubMed ID: 31682969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
